Posted on 11/24/2025 10:30:39 AM PST by SeekAndFind
Eli Lilly reached a $1 trillion market capitalization on Friday, the first health-care company in the world to join the exclusive club dominated by tech firms.
The drugmaker’s stock inched about 1% higher Monday, trading above the $1 trillion threshold. Eli Lilly is the second nontechnology company to reach that market cap milestone in the U.S. after Warren Buffett’s Berkshire Hathaway .
The company’s rise came as shares of its chief rival in the GLP-1 drug space, Novo Nordisk , tumbled about 6% in U.S. trading Monday. While Novo Nordisk’s stock fell after disappointing Alzheimer’s trial results, the drugmaker’s market share losses to Eli Lilly in obesity and diabetes drugs have led its stock to drop nearly 45% this year.
Meanwhile, Eli Lilly’s stock has climbed more than 37% this year as investors have applauded the gains it has made over Novo Nordisk in the booming space. The Indianapolis-based company’s stock has been riding the skyrocketing popularity of its weight loss injection Zepbound and diabetes treatment Mounjaro.
The two drugs have driven eye-popping sales growth for Eli Lilly. Last month, the company said Mounjaro drew in $6.52 billion in revenue in the third quarter, a 109% increase from the previous year. Meanwhile, Zepbound posted $3.59 billion in sales during the period, a 184% spike from the prior-year period.
Demand for the treatments will only grow as approvals for their use and insurance coverage expand. In addition, Eli Lilly expects an oral version of its popular drugs to hit the market next year, which could give patients a more convenient option than a shot that is easier for the company to produce.
Eli Lilly will likely remain a dominant player in the weight loss drug market, which some analysts believe could be worth more than $150 billion by the early 2030s.
(Excerpt) Read more at cnbc.com ...
Dear FRiends,
We need your continuing support to keep FR funded. Your donations are our sole source of funding. No sugar daddies, no advertisers, no paid memberships, no commercial sales, no gimmicks, no tax subsidies. No spam, no pop-ups, no ad trackers.
If you enjoy using FR and agree it's a worthwhile endeavor, please consider making a contribution today:
Click here: to donate by Credit Card
Or here: to donate by PayPal
Or by mail to: Free Republic, LLC - PO Box 9771 - Fresno, CA 93794
Thank you very much and God bless you,
Jim
The market value is crazy. $1 trillion for Eli Lilly is almost the size of the entire economy of the Netherlands and HIGHER than the GDP of Poland, Belgium, Swede, Ireland, Austria, Denmark, Portugal, Finland, Greece, etc.
Heck NVIDIA at $5 Trillion has a market value almost the size of Germany and greater than France and Italy!
There’s got to be a bubble here waiting to burst.
Don’t be a Debbie Downer. Nothing can stop this market( just like was said about the Titanic).
P/E ratios of Tesla, Nvidia, palantir etc are higher than my IQ, which is pretty high already, for a mechanical engineer with masters degree.
Yes, and earning will most likely never ever justify those super high P/E ratios. Most companies cannot sustain growth in earning year in and year out to justify current prices.
“Eli Lilly expects an oral version of its popular drugs to hit the market next year, which could give patients a more convenient option than a shot that is easier for the company to produce.”
- - - - - - -
I bet the much more convenient liquid version will triple the users.
And this will just add momentum to the new culture of taking pills instead of having a healthy life style.
People can eat soups to lose weight.
Insurance should not cover weight loss drugs.
Lets do Trumps plan! Give citizens the healthcare money, and the insurance companies can starve for a while.
Good old Colonel Lilly, RIP, is enjoying in his grave.
Surprisingly, Lilly is only ranked 11th on the list of biomedical companies by revenue.
For years, it was the solid middle of the pack company, producing benchmark medicines.
It stock exploded recently with introduction of the weight loss medicines Mounjaro and Zepbound.
Poor, starving Americans are buying them by tons!😊
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.